Causes of death among 91 HIV-infected adults in the era of potent antiretroviral therapy;Causes de décès de 91 patients ayant une infection à VIH traités par des antirétroviraux

Presse Medicale

Volumn 41, Issue 7-8, 2012, Pages

  Sodqi, Mustapha ^a   Marih, Latifa ^a   Lahsen, Ahd Oulad ^a   Bensghir, Rajae ^a   Chakib, Abdelfatah ^a   Himmich, Hakima ^b   El Filali, Kamal Marhoum ^a  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^b Association de lutte contre le sida (ALCS)   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; ASPERGILLOSIS; ATYPICAL MYCOBACTERIOSIS; BRAIN LYMPHOMA; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCOSIS; CRYPTOSPORIDIOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MOROCCO; NONHODGKIN LYMPHOMA; PUBLIC-PRIVATE PARTNERSHIP; RETROSPECTIVE STUDY; TOXOPLASMOSIS; TREATMENT DURATION; TUBERCULOSIS; UTERINE CERVIX CANCER; VIRUS LOAD; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOROCCO; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862630366     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.12.013     Document Type: Article

References (18)

1. Bozzette S.A., Ake C.F., Tam H.K., Phippard A., Cohen D., Scharestein D.O., et al. Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2008, 47:338-341.
2. Global report: UNAIDS report on the global AIDS epidemic 2010 http://www.unaids.og/.
3. Admou B., Elharti E., Oumzil H., Addebbous A., Amine M., Zahlane K., et al. Clinical and immunological status of a newly diagnosed HIV positive population in Marrakech, Morocco. Afr Health Sci 2010, 10(4):325-331.
4. Mocroft A., Brettle R., Kirk O., Blaxhult A., Parkin J.M., Antunes F., et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS 2002, 16:1663-1671.
5. Mermin J., Were W., Ekwaru J.P., Moore D., Downing R., Behumbiize P., et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 2008, 371:752-759.
6. Losina E., Figueroa P., Duncan J., Divi N., Wolf L.L., Hirschhorn L.R., et al. HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993-2005. Int J Infect Dis 2008, 12(2):132-138.
7. Lewden C., May T., Rosenthal E., Burty C., Bonnet F., Costagliola D., et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the Mortalité 2000 and 2005 surveys (ANRS EN 19 and Mortavic). J Acquir Immune Defic Syndr 2008, 48(5):590-598.
8. Macpherson P., Moshabela M., Martinson N., Pronyk P. Mortality and loss to follow-up among HAART initiators in rural South Africa. Trans R Soc Trop Med Hyg 2009, 103(6):588-593.
9. Louie J.K., Hsu L.C., Osmond D.H., Katz M.H., Schwarcz S.K. Trends in Causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis 2002, 186:1023-1027.
10. Lewden C., Salmon D., Morlat P., Bévilacqua S., Bonnet F., Héripret L., et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005, 34:121-130.
11. Lee YC, Wang JT, Sun HY, Chen YC. Comparaisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection. J Microbiol Immunol Infect 2011 doi:10.1016/j.jmii.2010.08.011.
12. May T., Lewden C., Bonnet F., Héripret L., Bevilacqua S., Jougla E., et al. Causes et caractéristiques des décès des patients infectés par le VIH-1, en succès immunovirologique sous traitement antirétroviral. Presse Med 2004, 33:1487-1492.
13. Crum N.F., Riffenburgh R.H., Wegner S., Agan B.K., Tasker S.A., Spooner K.M., et al. Comparisons of causes of death and mortality rates among HIV-infected persons, analysis of the pre-, early and late Highly Active Antiretroviral Therapy (HAART) Eras. J Acquir Immune Defic Syndr 2006, 41:194-200.
14. Braitstein P., Brinkhof M.W., Dabis F., Schechter M., Boulle A., Miotti P., et al. Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006, 367:817-824.
15. Sackoff J.E., Hanna D.B., Pfeiffer M.R., Torian L.V. Causes of death among persons with AIDS in the era of highly active. Antiretroviral therapy: New York City. Ann Intern Med 2006, 145:397-406.
16. Valdez H., Chowdhry T.K., Asaad R., Woolley I.J., Davis T., Davidson R., et al. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995-1999. Clin Infect Dis 2001, 32(15):1487-1493.
17. Gill J., May M., Lewden C., Saag M., Mugavero M., Reiss P., et al. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010, 50(10):1387-1396.
18. Leone S., Gregis G., Quinzan G., Velenti D., Cologni G., Ravasio V., et al. Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort. Infection 2011, 39(1):13-20.